SLNCF Silence Therapeutics plc
Price Chart
Executive Summary
Silence Therapeutics filed a prospectus supplement to activate an at-the-market (ATM) offering of up to $100M in ADSs through Jefferies. The ATM allows the company to sell shares opportunistically, creating immediate dilution of $3.98 per ADS at the assumed price of $6.10. The company had only $70.1M in cash and minimal revenue ($0.4M) as of March 31, 2026, and is burning cash ahead of Phase 2 data in August 2026.
Actionable Insight
The ATM creates overhang and likely near-term selling pressure as the company will need to raise funds to extend its cash runway. Monitor future 424B5 filings for actual sales activity; any disclosed sales will further pressure the stock. The Phase 2 SANRECO data in August 2026 is a key catalyst that could offset dilution if positive.
Key Facts
- ATM offering of up to $100,000,000 in ADSs through Jefferies LLC
- Jefferies receives 3.0% commission on gross sales price
- Immediate dilution of $3.98 per ADS to new investors
- Net tangible book value per ADS: $0.82 before offering, $2.12 after (assuming full $100M at $6.10/ADS)
- Stock closed at $6.64 on May 26, 2026 vs. assumed offering price of $6.10 per ADS
- Company had $70.1M cash and $0.4M revenue in Q1 2026, with a net loss of $15.0M
Financial Impact
Potential dilution of up to ~35% of outstanding shares (16.4M ADSs vs 47.2M outstanding) at maximum $100M offering, reducing existing holders' ownership stake
Risk Factors
- Continuous ATM sales may depress stock price
- Dilution of up to 35% if fully utilized
- Company has minimal revenue and is pre-commercial; cash burn continues
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-242060 |
| Document: 0001193125-26-242060-index-headers.html | 0001193125-26-242060 |
| Document: 0001193125-26-242060-index.html | 0001193125-26-242060 |
| Document: 0001193125-26-242060.txt | 0001193125-26-242060 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
16d ago
|
EFFECT
| $1.06 $1.06 | · 0.00% | ▲ +0.32% | $1.06 (+0.00%) |
|
May 27, 2026
16d ago
|
424B5
| $1.06 $1.06 | · 0.00% | ▲ +0.32% | $1.06 (+0.00%) |
|
May 18, 2026
25d ago
|
S-3
| $1.45 $1.06 | ▲ +27.02% | ▲ +29.32% | $1.06 (+27.02%) |
|
May 7, 2026
5w ago
|
8-K
| $2.63 $1.45 | ▼ −44.77% | ▼ −46.28% | $1.06 (−59.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access